Clinical presentation, diagnosis and survival of resected distal bile duct cancer

Alessandro Zerbi, Gianpaolo Balzano, Biagio E. Leone, Enzo Angeli, Paolo Veronesi, Valerio Di Carlo

Research output: Contribution to journalArticle

Abstract

The aim of the study was the definition of the clinical features and survival of 27 resected cases of distal bile duct carcinoma. This neoplasm accounted for 14% of all periampullary malignancies treated by pancreaticoduodenectomy between 1990 and 1996. Jaundice was present in 96% of patients, but was the first symptom only in 78%. Preoperative investigations allowed to recognize distal bile duct cancer in a minority of patients (41%). Operative mortality and morbidity were 3.7 and 44%, respectively. Most patients (88%) were assigned to UICC stage IV-A. Postoperative survival was not significantly better than survival of 101 patients undergoing pancreaticoduodenectomy for pancreatic ductal carcinoma; median survival was 22 months, with a 13% 5-year survival rate. Determinants of a better prognosis were UICC stage <IV-A (p = 0.05) and absence of lymphatic invasion (p <0.01); prognostic significance of nodal involvement, tumor grading, perineural invasion, tumor size, pylorus preservation and adjuvant therapies could not be proven. Lymphatic invasion was the strongest determinant of survival on multivariate analysis (p <0.01).

Original languageEnglish
Pages (from-to)410-416
Number of pages7
JournalDigestive Surgery
Volume15
Issue number5
DOIs
Publication statusPublished - 1998

Fingerprint

Bile Duct Neoplasms
Survival
Pancreaticoduodenectomy
Pancreatic Ductal Carcinoma
Neoplasms
Neoplasm Grading
Pylorus
Jaundice
Bile Ducts
Multivariate Analysis
Survival Rate
Morbidity
Carcinoma
Mortality

Keywords

  • Bile duct cancer
  • Jaundice
  • Lymphatic invasion
  • Pancreatic cancer
  • Pancreatoduodenectomy
  • Periampullary cancer

ASJC Scopus subject areas

  • Surgery

Cite this

Clinical presentation, diagnosis and survival of resected distal bile duct cancer. / Zerbi, Alessandro; Balzano, Gianpaolo; Leone, Biagio E.; Angeli, Enzo; Veronesi, Paolo; Di Carlo, Valerio.

In: Digestive Surgery, Vol. 15, No. 5, 1998, p. 410-416.

Research output: Contribution to journalArticle

@article{9afd4304aa7c47e58aca3d21adedeb95,
title = "Clinical presentation, diagnosis and survival of resected distal bile duct cancer",
abstract = "The aim of the study was the definition of the clinical features and survival of 27 resected cases of distal bile duct carcinoma. This neoplasm accounted for 14{\%} of all periampullary malignancies treated by pancreaticoduodenectomy between 1990 and 1996. Jaundice was present in 96{\%} of patients, but was the first symptom only in 78{\%}. Preoperative investigations allowed to recognize distal bile duct cancer in a minority of patients (41{\%}). Operative mortality and morbidity were 3.7 and 44{\%}, respectively. Most patients (88{\%}) were assigned to UICC stage IV-A. Postoperative survival was not significantly better than survival of 101 patients undergoing pancreaticoduodenectomy for pancreatic ductal carcinoma; median survival was 22 months, with a 13{\%} 5-year survival rate. Determinants of a better prognosis were UICC stage <IV-A (p = 0.05) and absence of lymphatic invasion (p <0.01); prognostic significance of nodal involvement, tumor grading, perineural invasion, tumor size, pylorus preservation and adjuvant therapies could not be proven. Lymphatic invasion was the strongest determinant of survival on multivariate analysis (p <0.01).",
keywords = "Bile duct cancer, Jaundice, Lymphatic invasion, Pancreatic cancer, Pancreatoduodenectomy, Periampullary cancer",
author = "Alessandro Zerbi and Gianpaolo Balzano and Leone, {Biagio E.} and Enzo Angeli and Paolo Veronesi and {Di Carlo}, Valerio",
year = "1998",
doi = "10.1159/000018654",
language = "English",
volume = "15",
pages = "410--416",
journal = "Digestive Surgery",
issn = "0253-4886",
publisher = "S. Karger AG",
number = "5",

}

TY - JOUR

T1 - Clinical presentation, diagnosis and survival of resected distal bile duct cancer

AU - Zerbi, Alessandro

AU - Balzano, Gianpaolo

AU - Leone, Biagio E.

AU - Angeli, Enzo

AU - Veronesi, Paolo

AU - Di Carlo, Valerio

PY - 1998

Y1 - 1998

N2 - The aim of the study was the definition of the clinical features and survival of 27 resected cases of distal bile duct carcinoma. This neoplasm accounted for 14% of all periampullary malignancies treated by pancreaticoduodenectomy between 1990 and 1996. Jaundice was present in 96% of patients, but was the first symptom only in 78%. Preoperative investigations allowed to recognize distal bile duct cancer in a minority of patients (41%). Operative mortality and morbidity were 3.7 and 44%, respectively. Most patients (88%) were assigned to UICC stage IV-A. Postoperative survival was not significantly better than survival of 101 patients undergoing pancreaticoduodenectomy for pancreatic ductal carcinoma; median survival was 22 months, with a 13% 5-year survival rate. Determinants of a better prognosis were UICC stage <IV-A (p = 0.05) and absence of lymphatic invasion (p <0.01); prognostic significance of nodal involvement, tumor grading, perineural invasion, tumor size, pylorus preservation and adjuvant therapies could not be proven. Lymphatic invasion was the strongest determinant of survival on multivariate analysis (p <0.01).

AB - The aim of the study was the definition of the clinical features and survival of 27 resected cases of distal bile duct carcinoma. This neoplasm accounted for 14% of all periampullary malignancies treated by pancreaticoduodenectomy between 1990 and 1996. Jaundice was present in 96% of patients, but was the first symptom only in 78%. Preoperative investigations allowed to recognize distal bile duct cancer in a minority of patients (41%). Operative mortality and morbidity were 3.7 and 44%, respectively. Most patients (88%) were assigned to UICC stage IV-A. Postoperative survival was not significantly better than survival of 101 patients undergoing pancreaticoduodenectomy for pancreatic ductal carcinoma; median survival was 22 months, with a 13% 5-year survival rate. Determinants of a better prognosis were UICC stage <IV-A (p = 0.05) and absence of lymphatic invasion (p <0.01); prognostic significance of nodal involvement, tumor grading, perineural invasion, tumor size, pylorus preservation and adjuvant therapies could not be proven. Lymphatic invasion was the strongest determinant of survival on multivariate analysis (p <0.01).

KW - Bile duct cancer

KW - Jaundice

KW - Lymphatic invasion

KW - Pancreatic cancer

KW - Pancreatoduodenectomy

KW - Periampullary cancer

UR - http://www.scopus.com/inward/record.url?scp=0031711618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031711618&partnerID=8YFLogxK

U2 - 10.1159/000018654

DO - 10.1159/000018654

M3 - Article

C2 - 9845623

AN - SCOPUS:0031711618

VL - 15

SP - 410

EP - 416

JO - Digestive Surgery

JF - Digestive Surgery

SN - 0253-4886

IS - 5

ER -